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Purpose: to assess the opinions regarding smoking ban policies in Switzerland. 
Methods: cross sectional study on 2,601 women and 2,398 men, aged 35-75 years, living in 
Lausanne, Switzerland. Nine questions on smoking policies (restrictions, advertising, taxes and 
prevention) were applied. 
Results: 95% of responders supported policies that would help smokers to quit, 92% supported 
no selling of tobacco to subjects aged less than 16 years, 87% a smoking ban in public places and 
86% a national campaign against smoking. A further 77% supported a total ban on tobacco 
advertising, 74% the reimbursement of nicotine replacement therapies and 70% increasing the 
price of cigarettes. Conversely, a lower support was found for a total ban of tobacco sales (35%) 
or the promotion of light cigarettes (22%). Multivariate analysis showed that women, lower 
educational level, older age, being physically active or non-smoker were associated with tougher 
policies against tobacco, whereas current drinking or smoking and higher educational level were 
associated with lower levels of support. 
Conclusion: opinions regarding smoking poli ci es vary considerably according to the policy type 
considered and also the characteristics of the subjects. Those findings provide interesting data 
regarding which anti-smoking policies would be more acceptable by the lay public, as weil as the 
subjects who might oppose them. 
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